The Technical Analyst
Select Language :
Getinge AB (publ) [GNGBY]

Exchange: OTC Sector: Healthcare Industry: Medical Devices

Getinge AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals

Getinge AB (publ) is listed at the  Exchange

0.80% $21.52

America/New_York / 3 mai 2024 @ 15:31


Getinge AB (publ): Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 5 795.67 mill
EPS: 0.770
P/E: 27.95
Earnings Date: Jul 18, 2024
SharesOutstanding: 269.32 mill
Avg Daily Volume: 0.0068 mill
RATING 2024-05-03
A
Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Buy
P/E: Buy
Price To Book: Neutral
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.96x
Company: PE 27.95 | sector: PE 29.05
PE RATIO: COMPANY / INDUSTRY
0.73x
Company: PE 27.95 | industry: PE 38.34
DISCOUNTED CASH FLOW VALUE
$32.07
(49.03%) $10.55
Date: 2024-05-05
Expected Trading Range (DAY)

$ 21.06 - 21.98

( +/- 2.12%)
ATR Model: 14 days

Forecast: 16:00 - $21.52

Live Trading Signals (every 1 min)

Forecast 1: 15:41 - $21.49
Forecast 2: 16:00 - $21.52
Forecast 3: 16:00 - $21.52
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price $21.52 (0.80% )
Volume 0.0047 mill
Avg. Vol. 0.0068 mill
% of Avg. Vol 68.37 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Getinge AB (publ)

Last 12 Months

Last 12 months chart data with high, low, open and close for Getinge AB (publ)

RSI

Last 10 Buy & Sell Signals For GNGBY

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Getinge AB (publ)

GNGBY

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Last 10 Buy Signals

Date Signal @
TIMEUSDMay 5 - 21:4932.42
WETHUSDMay 5 - 21:463 147.28
BTC.BUSDMay 5 - 21:4064 089
XMONUSDMay 5 - 21:42669.87
JUVUSDMay 5 - 21:422.61
P2PSUSDMay 5 - 21:40180.23
MUSEUSDMay 5 - 21:4214.62
GFARM2USDMay 5 - 21:413 523.33
FISUSDMay 5 - 21:420.563
BIFIUSDMay 5 - 21:40411.75

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.